Comparative efficacy of two combined cloned vaccines against Newcastle disease virus (NDV)

Home Knowledge Comparative efficacy of two combined cloned vaccines against Newcastle disease virus (NDV)

Comparative efficacy of two combined cloned vaccines against Newcastle disease virus (NDV)

This study comparatively assessed the safety and efficacy of two combined NDV/IB vaccines (HIPRAVIAR® CLON/H120 and a vaccine containing La Sota cloned/IB Ma5) in commercial layers.

About this article

Date

Jun 17, 2019

Authors

Dr. Sasipreeyajan, J.; Khanda, S.; Jongpattanasombat, S.; Keauwprachu, W.; Mansilla, A.; Dias, F.E.

Summary

This experiment confirmed the efficacy and safety of the use of combined vaccines (HIPRAVIAR® CLON/H120 or La Sota cloned/Ma5) for the control of Newcastle Disease in commercial layers against a controlled challenge with NDV virus genotype VII.

Related products

Share this on

The contents of this page are country specific and aimed specifically at prescribing veterinarians.

This product is not available in {{ preferredCountry.title }}.

You will be redirected to our global site. Click on continue to visit our global site (available in English).

Confirm that you are a veterinary professional:

This product is not available in {{ countrySelect.title }}.

You will be redirected to our global site. Click on continue to visit our global site (available in English).

  • I am a veterinarian (otherwise please contact a veterinary professional)

Select your country:

Country {{countrySelect.title}}
  • Global (available in English)
  • {{country.title}}
start portlet menu bar

Comparative efficacy of two combined cloned vaccines against Newcastle disease virus (NDV) and infectious bronchitis in a controlled NDV challenge in laying hens

Display portlet menu
end portlet menu bar